|  Help  |  About  |  Contact Us

Publication : CLEC9A is a novel activation C-type lectin-like receptor expressed on BDCA3+ dendritic cells and a subset of monocytes.

First Author  Huysamen C Year  2008
Journal  J Biol Chem Volume  283
Issue  24 Pages  16693-701
PubMed ID  18408006 Mgi Jnum  J:172970
Mgi Id  MGI:5009383 Doi  10.1074/jbc.M709923200
Citation  Huysamen C, et al. (2008) CLEC9A is a novel activation C-type lectin-like receptor expressed on BDCA3+ dendritic cells and a subset of monocytes. J Biol Chem 283(24):16693-701
abstractText  We describe here the first characterization of CLEC9A, a group V C-type lectin-like receptor located in the 'Dectin-1 cluster' of related receptors, which are encoded within the natural killer (NK)-gene complex. Expression of human CLEC9A is highly restricted in peripheral blood, being detected only on BDCA3(+) dendritic cells and on a small subset of CD14(+)CD16(-) monocytes. CLEC9A is expressed at the cell surface as a glycosylated dimer and can mediate endocytosis, but not phagocytosis. CLEC9A possesses a cytoplasmic immunoreceptor tyrosine-based activation-like motif that can recruit Syk kinase, and we demonstrate, using receptor chimeras, that this receptor can induce proinflammatory cytokine production. These data indicate that CLEC9A functions as an activation receptor.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

6 Bio Entities

Trail: Publication

0 Expression